Navigation Links
Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers
Date:12/15/2009

LAKE ZURICH, Ill., Dec. 15 /PRNewswire/ -- Fenwal Inc., a global leader focused on improving blood collection, safety and availability for patient care, reiterated its commitment to provide blood centers with Alyx® system supplies needed to collect lifesaving blood products, despite a new lawsuit filed yesterday against Fenwal by Haemonetics Corporation ( HAE). The Fenwal® Alyx® system, introduced in 2003, is an advanced medical instrument used worldwide to collect two units of red cells from a single donor in about 30 minutes.

Fenwal will ask the court to expedite the legal process to reduce the impact of delays on customers and the blood supply. The new lawsuit filed against Fenwal follows an earlier motion made by Fenwal before the same judge seeking a decision of non-infringement on its modified Alyx® separation chamber. In filing a second lawsuit now, Haemonetics has chosen to prolong the litigation.

Fenwal will vigorously defend itself in this new litigation and has taken several actions to assure uninterrupted product supply to blood centers. As previously announced, the company has modified the separation chamber in Alyx® kits to avoid infringing the disputed patent claim and to comply with the earlier court's judgment and injunction. Fenwal has openly informed Haemonetics of its redesign and introduction plans, including providing Haemonetics with drawings last April and production samples last September. In developing the modified Alyx® separation chamber, Fenwal followed strict design control procedures in accordance with all U.S. Food and Drug Administration regulations and guidance.

"We are committed to working with customers and assuring their operations are not disrupted as we continue to work through the steps required to resolve this," said Dean Gregory, Fenwal senior vice president of Commercial Operations. "We have said from the beginning that the claims against Fenwal have no merit and we will defend our position on behalf of our customers and employees. We also are continuing to develop new innovations for the Alyx® system that further improve the donor experience and help blood centers fulfill their mission with greater safety, quality and productivity."

Earlier this month, Fenwal began shipping Alyx® kits with the modified chamber and began discontinuing U.S. sales of the original chamber, nearly a year ahead of the December 2010 injunction date.

In addition, as previously announced, Fenwal has appealed the original judgment of infringement on several strong grounds. It has also asked the U.S. Patent Office to reconsider the validity of the disputed patent.

Fenwal developed and introduced the Alyx® system independent of the disputed patent. Haemonetics, which purchased the patent from a third-party inventor, has not incorporated the technology into any commercial product.

About Fenwal

Fenwal Inc. is a global medical technology company focused on improving blood collection, separation, safety and availability for patient care. Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories. Fenwal developed the first flexible, disposable container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components. Today, the company's products and advanced collection and separation technologies are used throughout the world to help ensure a safe and available supply of lifesaving blood and blood products. Fenwal Inc. is based in Lake Zurich, Illinois. For more information, please visit www.fenwalinc.com.

SOURCE Fenwal Inc.


'/>"/>
SOURCE Fenwal Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Fenwal Receives FDA Approval for New Solution Used to Store Donated Blood Platelets
2. William Cork Joins Fenwal as Chief Technology Officer
3. Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients
4. Endologix Responds to Alleged Patent Infringement
5. EPSScentral Responds to Pandemic Alert
6. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
7. GSK Believes There Is No Liver Safety Issue With AVANDIA; Responds to Public Citizen Petition
8. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
9. Roche responds to announcement of IDEAL hepatitis C trial results
10. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
11. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 26, 2016 ... care operating models within the health care industry is ... financial efficiency , Deloitte offers a suite of ... business issues impacting efficient cost optimization: labor resource analysis, ... These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... Calif. , June 24, 2016  Global ... a biopharmaceutical company developing novel therapeutics for the ... needs, today announced the closing of its previously ... common stock, at the public offering price of ... the offering were offered by GBT. GBT estimates ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... 24, 2016 , ... People across the U.S. are sharpening their pencils and ... essay contest in which patients and their families pay tribute to a genetic counselor ... National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , ...
(Date:6/24/2016)... Nevada (PRWEB) , ... June 24, 2016 , ... ... Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations ... in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, ... organization dedicated to helping service members that have been wounded in battle and their ...
Breaking Medicine News(10 mins):